|
|
|
|
| LEADER |
01147naa a2200301 i 4500 |
| 001 |
NSK01001019385 |
| 003 |
HR-ZaNSK |
| 005 |
20190218164012.0 |
| 007 |
ta |
| 008 |
190201s2016 ci a | |0|| ||eng |
| 035 |
|
|
|a (HR-ZaNSK)001019385
|
| 040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
| 042 |
|
|
|a croatica
|
| 044 |
|
|
|a ci
|c hr
|
| 080 |
1 |
|
|a 615
|2 2011
|
| 080 |
1 |
|
|a 332
|2 2011
|
| 100 |
1 |
|
|a Mance, Diana
|4 aut
|
| 245 |
1 |
0 |
|a Incremental cost-effectiveness pharmacoeconomic assessment of hepatitis C virus therapy :
|b an approach for less wealthy members of the common market /
|c Diana Mance, Davor Mance, Dinko Vitezić.
|
| 300 |
|
|
|b Ilustr.
|
| 504 |
|
|
|a Bibliografija: 28 jed.
|
| 653 |
|
0 |
|a Farmakoekonomika
|a Hepatitis C
|a Terapija lijekovima
|a Farmakoterapija
|a Isplativost
|a Analiza troškova i koristi
|
| 653 |
|
5 |
|a Hrvatska
|
| 700 |
1 |
|
|a Mance, Davor,
|c ekonomist
|4 aut
|
| 700 |
1 |
|
|a Vitezić, Dinko,
|c liječnik
|4 aut
|
| 773 |
0 |
|
|t Croatian medical journal
|x 0353-9504
|g 57 (2016), 6 ; str. 582-590
|w nsk.(HR-ZaNSK)000006721
|
| 981 |
|
|
|b B05/16
|
| 998 |
|
|
|b gtao1902
|b mili1902
|
| 856 |
4 |
1 |
|u Elektronička verzija članka
|y https://hrcak.srce.hr/181398
|